GlassScriptPhysician profile
Michael P Jones
NPI 1164589164
$19,601.94
in general payments reported to CMS, 2019-2025
15 companies · $932 in 2025
The $932 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $4,332 · 2021: $5,965 · 2022: $643 · 2023: $3,189 · 2024: $3,944 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,289 · Food and Beverage: $2,719 · Travel and Lodging: $57.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,289.25 |
| Food and Beverage | $2,718.92 |
| Travel and Lodging | $57.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $14,418.03 | 2019-2025 | Argos, Acrysof Iq Vivity, Clareon |
| Alcon Research LLC | $4,064.25 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $278.65 | 2021-2023 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $162.81 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Ivantis, INC | $143.30 | 2020 | |
| Novartis Pharmaceuticals Corporation | $129.74 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $102.16 | 2024-2025 | Xdemvy |
| Abbvie INC. | $65.13 | 2024-2025 | |
| Dompe US, INC. | $64.18 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $54.32 | 2024-2025 | Scoutpro Osmolarity System |
| Harrow Eye, LLC | $49.58 | 2024-2025 | Vevye |
| Glaukos Corporation | $22.70 | 2025 | Idosetr |
| Tearlab Corp | $17.66 | 2024 | Scoutpro Osmolarity System |
| Sun Pharmaceutical Industries INC. | $16.06 | 2020 | |
| Galderma Laboratories, L.P. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.